Event overview

Conversations for Change: Shaping the Future of Essential Medicines (Hybrid Symposium)

ITM community and partners in dialogue with The Lancet Commission on accelerating the progress on essential medicines.
-

Live at ITM and online

Show route
Register now
Planet in Pills by Gautam

About this event

The 1977 Model List of Essential Medicines and the subsequent Action Programme on Essential Medicines of the World Health Organization (WHO) are widely regarded as among the most influential public health achievements of the late 20th century. The essential medicines concept, grounded in equity and efficiency, has since been adopted in more than 150 countries. More recently, the European Union has introduced the concept of critical medicines, with the goal of diversifying pharmaceutical manufacturing and preventing stock-outs of key products.

Today, instability, migration, climate change, pandemics, artificial intelligence, decreasing financial investment in health, and the rapid transformation of multilateral institutions among other challenges require critical reflection on the future of the essential medicines framework. The Lancet Commission, launched in 2025, aims to provide such reflection, with its final report planned for publication in 2027.

Ensuring global access to essential medicines continues to be central to advancing universal health coverage. The Institute of Tropical Medicine (ITM) is a global leader in evidence generation, education, and health services in tropical medicine and global health, strongly committed to health equity, particularly in low‑ and middle‑income countries and in vulnerable populations. Pharmaceutical public health, formally established as a research unit within the Department of Public Health, is an increasingly important focus area within ITM.

Goal

  1. Discuss gaps in current knowledge in essential medicines

  2. Identify opportunities to strengthen the Commission's and ITM evidence generation and advocacy in essential medicines

  3. Formulate recommendations to advance research and advocacy in the field of pharmaceutical public health

For whom?

Experts, students in pharmaceutical public health, academic institutions across Belgium and Europe, research funders, policy makers, and members of the Lancet Commission who are interested in ensuring global access to essential medicines.

Format

Participation is possible both in person and online. Online participants can join the event via the Zoom link.

Practical information

Date: 12 June 2026
Time:
10:00-14:00 (CEST)
Format: Hybrid (in person and online)
Location:
Aula Janssens, Campus Rochus
Sint-Rochusstraat 43, 2000 Antwerp


This event has passed. We look forward to welcoming you at another event.

Browse upcoming events

Pictures

ConversationsforChange1_5x4
ConversationsforChange2_5x4
ConversationsforChange3_5x4
ConversationsforChange4_5x4
ConversationsforChange5_5x4
ConversationsforChange6_5x4

Programme

Timing

Activity

Speaker(s)

09:30-10:00

Arrivals

10:00-10:15

Welcome

  • Özge Tunçalp (Executive Director, ITM)

  • Raffaella Ravinetto (Head of Public Health Department and Professor of Pharmaceutical Public Health, ITM)

10:15-10:45

Opening remarks from The Lancet Commission

  • Veronika Wirtz (Boston University )

  • Hans Hogerzeil (University of Groningen)

10:45-11:45

Short talks from the ITM community: Some key challenges inpublic pharmaceuticals

  1. Barriers to compassionate use of medicines for MDR and XDR TB

  2. Access to adequate medicines for children: persisting neglect and gaps

  3. Old and new access challenges around medicines for HIV PrEP

  4. Access to medicines for neglected tropical diseases during the pre-elimination phase: the case of leishmaniasis

  5. Controlled medicines: the access gap between the Global North and South

  1. Anita Mesic (ITM)

  2. Jacquie Oliwa (ITM)

  3. Thijs Reyniers (ITM)

  4. Johan Van Griensven (ITM)

  5. Belen Tarrafeta (ITM)

11:45-13:00

Panel discussion and Q&A session: Priorities for evidence generation on essential and critical medicines

Panelists

  • Michael Makanga (Executive Director of Global Health EDCTP3)

  • Tine Carmeliet (Advisor of the Cabinet of the Minister of Health, Belgium)

  • Areen Altaany (Representative of the ITM Pharmaceutical Public Health course)

  • Andy Gray (The Lancet Commission)

  • Lorenzo Moja (Secretariat of the WHO Model List of Essential Medicines)

Moderators

  • Raffaella Ravinetto (ITM)

  • Saleh Aljadeeah (ITM and The Lancet Commission)

13:00-14:00

Closing remarks and network lunch

  • Özge Tunçalp (Executive Director, ITM)

  • Hans Hogerzeil (The Lancet Commission)

Spread the word! Share this event on